The new approaches were extensively reviewed in 2021 and 2022 but count intensely on region and region-specific dynamic versions for lower and Center-income countries that skilled important COVID-associated disruptions to TB diagnosis and therapy, during the absence of trusted direct measurements of illness load from countrywide disorder surveillance programs or https://us.hc6.org/